Menopause and women?s cardiovascular health: is it really an obvious relationship?

被引:52
作者
Ryczkowska, Kamila [1 ]
Adach, Weronika [1 ,3 ]
Janikowski, Kamil [1 ,2 ]
Banach, Maciej [1 ,2 ]
Bielecka-Dabrowa, Agata [1 ,2 ]
机构
[1] Med Univ Lodz, Dept Prevent Cardiol & Lipidol, Lodz, Poland
[2] Polish Mothers Mem Hosp Res Inst PMMHRI, Dept Cardiol & Congenital Dis Adults, Lodz, Poland
[3] Med Univ Lodz, Chair Nephrol & Hypertens, Dept Prevent Cardiol & Lipidol, 4 Kosciuszki St, PL-90419 Lodz, Poland
关键词
cardiovascular diseases; hypertension; hormone therapy; lipid; disease; rheumatic heart disease; arterial disease; peripheral arterial; HORMONE-REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; METABOLIC SYNDROME; DIABETES-MELLITUS; ESTROGEN; RISK; DISEASE; METAANALYSIS; LIPOPROTEIN; MECHANISMS;
D O I
10.5114/aoms/157308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases are common for men and women but there are differences between the sexes in terms of clinical symptoms, pathophysiology and response to the treatment. Cardiovascular diseases (CVD) in women is commonly underdiagnosed and often women tend to have a lower perception of the risk. That can lead to delayed diagnosis and failed recognition of symptoms. Women develop heart diseases later than men because of the protection in the reproductive phase of their life. Once they enter menopause the risk increases. Estrogen provides a protective effect against heart disease in women. Therefore, the risk of CVD increases after menopause in most cases. The presented work emphasizes the importance of the menopausal period as the time of increasing CVD risk. It also emphasizes the importance of monitoring the health of women in their middle age, a critical time in which early intervention strategies should be implemented to reduce the risk of CVD.
引用
收藏
页码:458 / 466
页数:9
相关论文
共 62 条
[41]  
Newson Louise, 2018, Post Reprod Health, V24, P44, DOI 10.1177/2053369117749675
[42]   Can the effects of gender, menopause and ageing on lipid levels be differentiated? [J].
Nikolic, Dragana ;
Banach, Maciej ;
Mikhailidis, Dimitri P. ;
Rizzo, Manfredi .
CLINICAL ENDOCRINOLOGY, 2016, 85 (05) :694-695
[43]   The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review [J].
Oliver-Williams, Clare ;
Glisic, Marija ;
Shahzad, Sara ;
Brown, Elizabeth ;
Baena, Cristina Pellegrino ;
Chadni, Mahmuda ;
Chowdhury, Rajiv ;
Franco, Oscar H. ;
Muka, Taulant .
HUMAN REPRODUCTION UPDATE, 2019, 25 (02) :257-271
[44]   Risk factors associated with coronary artery calcification in midlife women: a population-based study [J].
Oppermann, Karen ;
Colpani, Veronica ;
Spritzer, Poli Mara .
GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (10) :904-908
[45]   The outcomes of hypertension treatment depending on gender in patients over 40 years of age [J].
Paduszynska, Aleksandra ;
Banach, Maciej ;
Maciejewski, Marek ;
Dabrowa, Marek ;
Bielecka-Dabrowa, Agata .
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2020, 19 (04) :174-178
[46]   Cardioprotective properties of leptin in patients with excessive body mass [J].
Paduszynska, Aleksandra ;
Sakowicz, Agata ;
Banach, Maciej ;
Maciejewski, Marek ;
Dabrowa, Marek ;
Bielecka-Dabrowa, Agata .
IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (04) :1259-1265
[47]   Therapeutic strategies for type 2 diabetes mellitus in women after menopause [J].
Paschou, Stavroula A. ;
Marina, Ljiljana, V ;
Spartans, Eleftherios ;
Anagnostis, Panagiotis ;
Alexandrou, Andreas ;
Goulis, Dimitrios G. ;
Lambrinoudaki, Irene .
MATURITAS, 2019, 126 :69-72
[48]   Novel mechanisms responsible for postmenopausal hypertension [J].
Reckelhoff, JF ;
Fortepiani, LA .
HYPERTENSION, 2004, 43 (05) :918-923
[49]   Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial [J].
Rossouw, JE ;
Anderson, GL ;
Prentice, RL ;
LaCroix, AZ ;
Kooperberg, C ;
Stefanick, ML ;
Jackson, RD ;
Beresford, SAA ;
Howard, BV ;
Johnson, KC ;
Kotchen, JM ;
Ockene, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :321-333
[50]   Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women [J].
Salpeter, S. R. ;
Walsh, J. M. E. ;
Ormiston, T. M. ;
Greyber, E. ;
Buckley, N. S. ;
Salpeter, E. E. .
DIABETES OBESITY & METABOLISM, 2006, 8 (05) :538-554